Cofar-XL Junior Syrup (60ml)

Ambroxol 15 mg + Levosulbutamol 0.5 mg + Guaifenesin Junior Cough Syrup

Cofar-XL Junior Syrup (60ml) — Ambroxol HCl 15 mg + Levosulbutamol 0.5 mg + Guaifenesin per 5 ml from Trumac Healthcare PCD Pharma Franchise India

Composition Ambroxol HCl 15 mg + Levosulbutamol 0.5 mg + Guaifenesin per 5 ml
Dosage Form Oral Syrup
Pack Type Bottle
Pack Size 60 ml Bottle
MRP ₹ 84.7
Therapy Paediatric + G.P. — Mucolytic + Beta-2 Agonist + Expectorant (Junior)
Storage Store below 30 °C in a dry place. Shake well before use.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Cofar-XL Junior Syrup (60ml)

Cofar-XL Junior Syrup combines Ambroxol 15 mg + Levosulbutamol 0.5 mg + Guaifenesin per 5 ml. The ‘XL’ formulation replaces Terbutaline with Levosulbutamol — the R-enantiomer of salbutamol with comparable bronchodilation and significantly fewer cardiac side effects (tremor, tachycardia) than the racemic mixture.

Used for productive cough with bronchospasm in young children — particularly when minimising tremor and palpitations is important. The junior strength is dosed appropriately for younger children.

Cofar-XL Junior is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Paediatric productive cough with bronchospasm
  • Acute bronchitis with wheezing
  • Mild paediatric asthma exacerbations
  • Cough with bronchospasm preferring lower cardiac side effects

Mechanism of Action

Ambroxol reduces mucus viscosity. Levosulbutamol selectively activates β2 receptors with fewer cardiac effects than racemic salbutamol. Guaifenesin enhances mucus clearance.

Dosage & Administration

Children 2–6 years: 2.5 ml three times daily. Children 6–12 years: 5 ml three times daily.

Side Effects

Less tremor and palpitations than Terbutaline-containing syrups. Mild nausea.

Contraindications & Precautions

Hypersensitivity. Tachyarrhythmias.

Storage

Store below 30 °C in a dry place. Shake well before use.

PCD Pharma Franchise & Third-Party Manufacturing
Cofar-XL Junior Syrup (60ml) is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Cofar-XL Junior used for?

Cofar-XL Junior contains Ambroxol + Levosulbutamol + Guaifenesin junior. Used as per the indications described above.

How should Cofar-XL Junior be taken?

As directed by your physician. Complete the prescribed course.

Is Cofar-XL Junior available for PCD pharma franchise?

Yes, Trumac Healthcare offers Cofar-XL Junior on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Cofar-XL Junior be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Cofar-XL Junior WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.